Management's Objection regarding claims on account of Equity Interest was not what I had hoped it would be. Here is a list of the claimants, in this regard, in case you haven't seen it.
I mention it because I did not see Cheryl Buxton's name on it. But the list I saw did mention John Hohneker and Kevin Xie. Now, I see none of the three.
Maybe I need SG44's eyes on this, or maybe I need to finish my first cup of coffee. But I think there has to be another version of the list somewhere.
I just find it a little curious. I still believe that we will have a successful conclusion by the time additional information relative to the co-exclusive licensing deal between Sanofi and Novavax is made known.